查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887018

心臟病學正子斷層掃描 (PET) 市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，以及 2024 年至 2032 年的預測

Cardiology Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

心臟病學正子斷層掃描 (PET) 市場成長驅動因素

隨著全球對先進的非侵入性心臟診斷工具的需求不斷增長，全球心臟病學正子斷層掃描 (PET) 市場持續擴張。根據最近的一份報告，受心臟病患病率上升、成像系統技術進步以及精準診斷日益普及的推動，全球心臟病學正電子發射斷層掃描 (PET) 市場規模預計在 2024 年將達到 19.1 億美元。受人口老化和臨床對早期、精準心臟評估日益增長的需求驅動，預計該市場將穩步增長，到 2025 年達到 19.7 億美元。展望未來，預計到 2032 年，該市場將成長至 25.6 億美元，2025 年至 2032 年的複合年增長率 (CAGR) 為 3.8%。

2024 年，北美以 55.49% 的市場佔有率引領全球市場，這得益於其強大的醫療保健基礎設施、混合 PET/CT 系統的快速普及以及心臟成像領域持續不斷的產品審批。

市場驅動因素

透過技術創新提高診斷準確性

先進的 PET/CT 和 PET/MRI 掃描儀的日益普及是推動心臟 PET 影像變革的關鍵因素。領先企業正大力投資人工智慧驅動的影像系統，這些系統可提供更高的精確度、更快的掃描速度，並改善心肌灌注、冠狀動脈血流儲備和發炎的可視化效果。這些創新有助於提升臨床決策水平，並支持個人化治療策略。

2024年6月，西門子醫療推出Biograph Trinion PET/CT掃描儀，標誌著其發展歷程中的重要里程碑。該掃描儀採用人工智慧驅動的工作流程和整合式患者監護功能。此外，2024年9月，GE醫療的下一代PET MPI追蹤劑Flyrcado（Flupiridaz F 18）獲得FDA批准，用於診斷冠狀動脈疾病（CAD）。這些進展凸顯了下一代心臟影像系統在全球日益普及的現象。

市場限制因子

設備成本高且缺乏熟練專業人員

儘管PET/CT系統在診斷方面非常重要，但其價格昂貴，介於22.5萬美元至75萬美元之間，這使得中小型醫療機構難以實施，從而限制了市場。

此外，核醫專業人員的短缺，包括核醫技師、放射性藥物專家和心臟影像醫師，也是一項重大挑戰。缺乏培訓機會和嚴格的監管要求減緩了其普及速度，尤其是在新興市場。

市場機會

對先進影像和工作流程最佳化的需求不斷增長

全球心血管疾病（CVD）負擔日益加重，推動了對早期診斷和改善治療方案的需求。這為提供速度更快、解析度更高、工作流程更有效率的成像系統的製造商創造了巨大的機會。

技術開發商與診斷服務提供者之間的合作正在加速市場擴張。例如，IONETIX 與 Provision Diagnostic Imaging 於 2024 年 2 月簽署的合作協議旨在提高放射性示蹤劑的供應量並加快診斷結果的出具。

市場挑戰

放射性示蹤劑供應短缺

放射性示蹤劑短缺仍然是全球市場的一大瓶頸。許多示踪劑的半衰期很短，需要附近的加速器設施。 2024 年 10 月，英國國家醫療服務體系 (NHS) 報告放射性同位素嚴重短缺，導致全國心臟影像手術的延誤。這些供應鏈波動阻礙了穩定運營，並限制了高價值 PET 系統的充分利用。

依細分市場概覽

依付款方式

2024年，由於審批流程更快、醫療服務提供者選擇更多以及個人化治療方案，私人醫療保險/自費市場將引領市場成長。

在CMS等監理機關提出的報銷改革方案的支持下，公共醫療保險市場預計將實現溫和成長。

依服務提供者

2024年，由於擁有先進的影像基礎設施和熟練的醫護人員，醫院佔了最大的市場佔有率。

由於等待時間縮短、成本優勢以及PET/CT系統採購方面合作增多，診斷中心預計將以最高的複合年增長率增長。

區域洞察

北美

北美在2024年以10.6億美元的市場規模領跑，這主要得益於冠狀動脈疾病（CAD）的高發病率以及對精準診斷的大力投資。美國仍然是最大的貢獻者，這得益於醫院和影像網路持續的產品應用和PET/CT設備的升級。

歐洲

歐洲在2024年維持了顯著的市場佔有率，這主要得益於醫療保健的數位化程度不斷提高以及主要PET設備製造商的存在。對診斷技術現代化的投資將繼續推動該地區的成長。

亞太地區

預計亞太地區在預測期內將實現最高的複合年增長率，這主要得益於醫療保健投資的增加、先進影像技術的普及以及放射性藥物研發領域合作的拓展。

拉丁美洲和中東及非洲

由於心血管疾病 (CVD) 發病率上升、醫療保健支出增加以及技術逐步普及，因此兩個地區預計將保持穩定增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 近期產業發展動態，包括合作、併購
  • 部分國家心臟病盛行率（2024 年）
  • 新產品發布
  • 主要產業趨勢與主要參與者

第五章 全球心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測 (2019-2032)

  • 市場分析、洞察與預測 - 依支付方式劃分
    • 公共支付
    • 私人醫療保險/自費
  • 市場分析、洞察與預測 - 依服務提供者劃分
    • 醫院
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美正子斷層掃描心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測 (2019-2032)

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測 (2019-2032)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲心臟病學正子斷層掃描 (PET) 市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析 (2024)
  • 公司簡介
    • RadNet, Inc.
    • Sonic Healthcare Limited
    • Akumin Inc.
    • Apex Radiology
    • Alliance Medical Limited
    • Novant Health
    • InHealth Group
    • Dignity Health
    • Concord Medical
    • Siemens Healthcare Limited
    • Mediworks
    • 其他主要參與者
Product Code: FBI113310

Growth Factors of cardiology positron emission tomography (PET) scan Market

The global cardiology positron emission tomography (PET) scan market continues to expand as demand for advanced non-invasive cardiac diagnostic tools increases worldwide. According to the latest report, the global cardiology PET scan market size was valued at USD 1.91 billion in 2024, supported by rising cardiac disease prevalence, technological advancements in imaging systems, and greater adoption of precision diagnostics. The market is expected to reach USD 1.97 billion in 2025, reflecting steady growth driven by the rising geriatric population and increasing clinical preference for early and accurate cardiac evaluations. Looking ahead, the market is forecast to grow to USD 2.56 billion by 2032, exhibiting a CAGR of 3.8% from 2025 to 2032.

In 2024, North America dominated the global market with a 55.49% share, fueled by strong healthcare infrastructure, rapid adoption of hybrid PET/CT systems, and continual product approvals in the cardiac imaging domain.

Market Drivers

Technological Advancements Amplify Diagnostic Precision

The increasing introduction of advanced PET/CT and PET/MRI scanners is a key driver transforming cardiology PET imaging. Major players are heavily investing in AI-enabled imaging systems that offer superior accuracy, faster scan times, and enhanced visualization of myocardial perfusion, coronary flow reserve, and inflammation. These innovations strengthen clinical decision-making and support personalized treatment strategies.

A significant milestone was achieved in June 2024, when Siemens Healthineers launched its PET/CT scanner Biograph Trinion, featuring AI-driven workflows and integrated patient monitoring. Additionally, in September 2024, GE HealthCare received FDA approval for Flyrcado (flurpiridaz F 18), a next-generation PET MPI tracer for diagnosing Coronary Artery Disease (CAD). These advancements highlight the growing adoption of next-level cardiac imaging systems globally.

Market Restraints

High Equipment Costs and Shortage of Skilled Professionals

Despite its diagnostic significance, the market faces limitations due to the high cost of PET/CT systems, which ranges between USD 225,000 and USD 750,000, making these systems difficult to adopt in small and mid-sized healthcare settings.

Furthermore, the shortage of nuclear medicine professionals-including nuclear technologists, radiopharmaceutical specialists, and cardiac imaging physicians-remains a major challenge. Insufficient training opportunities and stringent regulatory requirements slow down widespread adoption, particularly in emerging markets.

Market Opportunities

Growing Demand for Advanced Imaging and Workflow Optimization

The rising global burden of cardiovascular diseases (CVDs) has heightened the demand for early diagnosis and improved treatment planning. This creates strong opportunities for manufacturers offering faster, high-resolution, and workflow-efficient imaging systems.

Partnerships between technology developers and diagnostic providers are accelerating market expansion. For example, IONETIX's partnership with Provision Diagnostic Imaging in February 2024 aims to improve radiotracer availability and reduce diagnostic turnaround times.

Market Challenges

Limited Radiotracer Availability

Radiotracer shortages remain a critical bottleneck for the global market, as many tracers require nearby cyclotron facilities due to their short half-life. In October 2024, the U.K.'s NHS reported severe radioisotope shortages that led to nationwide delays in cardiac imaging procedures. These supply chain fluctuations hinder consistent operations and limit the full utilization of high-value PET equipment.

Segmental Overview

By Source of Payment

The private health insurance/out-of-pocket segment dominated the market in 2024 due to faster approvals, wider provider choice, and personalized treatment packages.

The public segment is expected to witness moderate growth, supported by revised reimbursement proposals from regulatory agencies such as CMS.

By Service Provider

In 2024, hospitals held the largest market share, supported by advanced imaging infrastructure and availability of skilled staff.

Diagnostic centers are projected to grow at the fastest CAGR due to shorter waiting times, cost advantages, and increasing partnerships for PET/CT system procurement.

Regional Insights

North America

North America led the market with USD 1.06 billion in 2024, driven by high CAD prevalence and strong investments in precision diagnostics. The U.S. remains the largest contributor, supported by continual product installations and PET/CT upgrades across hospitals and imaging networks.

Europe

Europe held a substantial market share in 2024, supported by healthcare digitalization initiatives and the presence of leading PET device manufacturers. Investments in diagnostic modernization continue to strengthen regional growth.

Asia Pacific

Asia Pacific is projected to record the highest CAGR during the forecast period due to rising healthcare investments, improved access to advanced imaging, and growing collaborations for radiopharmaceutical development.

Latin America & Middle East/Africa

Both regions are witnessing steady growth driven by increasing CVD incidence, rising healthcare spending, and gradual technology adoption.

Conclusion

With the market expanding from USD 1.91 billion in 2024 to USD 2.56 billion by 2032, the global cardiology PET scan market is poised for consistent growth. Advancements in imaging technologies, expanding diagnostic infrastructure, and rising cardiac disease prevalence will continue to shape the industry's future.

Segmentation By Source of Payment

  • Public
  • Private Health Insurance/Out-of-pocket

By Service Provider

  • Hospitals
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Source of Payment, Service Provider, and Country)
    • U.S.
    • Canada
  • Europe (By Source of Payment, Service Provider, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Source of Payment, Service Provider, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Source of Payment, Service Provider, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Source of Payment, Service Provider, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Recent Industry Developments such as Partnerships, Mergers, and Acquisitions
  • 4.2. Prevalence of Cardiac Conditions, Key Countries, 2024
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments, Key Players

5. Global Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.1.1. Public
    • 5.1.2. Private Health Insurance/Out-of-pocket
  • 5.2. Market Analysis, Insights and Forecast - By Service Providers
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.1.1. Public
    • 6.1.2. Private Health Insurance/Out-of-pocket
  • 6.2. Market Analysis, Insights and Forecast - By Service Providers
    • 6.2.1. Hospitals
    • 6.2.2. Diagnostic Centers
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.1.1. Public
    • 7.1.2. Private Health Insurance/Out-of-pocket
  • 7.2. Market Analysis, Insights and Forecast - By Service Providers
    • 7.2.1. Hospitals
    • 7.2.2. Diagnostic Centers
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia pacific Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.1.1. Public
    • 8.1.2. Private Health Insurance/Out-of-pocket
  • 8.2. Market Analysis, Insights and Forecast - By Service Providers
    • 8.2.1. Hospitals
    • 8.2.2. Diagnostic Centers
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.1.1. Public
    • 9.1.2. Private Health Insurance/Out-of-pocket
  • 9.2. Market Analysis, Insights and Forecast - By Service Providers
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic Centers
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.1.1. Public
    • 10.1.2. Private Health Insurance/Out-of-pocket
  • 10.2. Market Analysis, Insights and Forecast - By Service Providers
    • 10.2.1. Hospitals
    • 10.2.2. Diagnostic Centers
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. RadNet, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Sonic Healthcare Limited
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Akumin Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Apex Radiology
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Alliance Medical Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Novant Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. InHealth Group
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Dignity Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Concord Medical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Siemens Healthcare Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Mediworks
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Other Prominent Players
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 2: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 3: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 4: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 5: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 6: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 7: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 8: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 9: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 10: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 11: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 12: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 14: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 15: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 17: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 18: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Cardiology Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024 & 2032
  • Figure 3: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024 & 2032
  • Figure 4: Global Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Region, 2024 & 2032
  • Figure 5: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 6: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 7: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 8: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 9: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country, 2024 & 2032
  • Figure 10: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country, 2024
  • Figure 11: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 12: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 13: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 14: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 15: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 16: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 17: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 18: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 19: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 20: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 21: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 22: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 23: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 24: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 25: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 26: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 27: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 28: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 29: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 30: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 31: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 32: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 33: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 34: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 35: Global Cardiology Positron Emission Tomography Scan Market Share (%), By Company, 2024